From: Research trajectory of the mechanism of preeclampsia: a scientometric perspective
Keywords | Years | Strength | Begin | End | 1980–2024 |
---|---|---|---|---|---|
Preeclampsia | 1991 | 20.87 | 1991 | 2004 | |
Release | 1991 | 10.65 | 1991 | 2005 | |
Pregnancy induced hypertension | 1992 | 33.6 | 1992 | 2005 | |
Prostacyclin | 1992 | 13.48 | 1992 | 2005 | |
Endothelial cell | 1993 | 19.4 | 1993 | 2008 | |
Plasma | 1993 | 16.68 | 1993 | 2005 | |
Intrauterine growth retardation | 1993 | 11.44 | 1993 | 2010 | |
Tumor necrosis factor | 1995 | 15.53 | 1995 | 2011 | |
Blood pressure | 1991 | 10.52 | 1995 | 2001 | |
Nitric oxide | 1996 | 9.17 | 1996 | 2013 | |
Lipid peroxidation | 1998 | 11.06 | 1998 | 2015 | |
Normal pregnancy | 1991 | 14.78 | 2002 | 2012 | |
Nitric oxide synthase | 2001 | 11.48 | 2003 | 2011 | |
Necrosis factor alpha | 2001 | 13.7 | 2006 | 2015 | |
Endothelial growth factor | 1999 | 12.91 | 2006 | 2015 | |
Circulating angiogenic factor | 2007 | 14.29 | 2007 | 2015 | |
Soluble endoglin | 2007 | 10.85 | 2009 | 2015 | |
Uterine artery doppler | 2007 | 9.34 | 2010 | 2013 | |
Agonistic autoantibody | 2011 | 11.48 | 2011 | 2016 | |
Proliferation | 2012 | 9.17 | 2019 | 2020 | |
Trophoblast cell | 2007 | 12.65 | 2020 | 2024 | |
Impact | 2018 | 10.47 | 2021 | 2024 | |
Extracellular vesicle | 2017 | 9.47 | 2021 | 2024 | |
Circular rna | 2020 | 9.26 | 2021 | 2024 | |
Pathophysiology | 2010 | 18.87 | 2022 | 2024 |